spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

4th Annual Formulation & Drug Delivery Congress

8-9 May 2018
London, UK

Oxford Global are proud to present our hugely popular 4th Annual Formulation & Drug Delivery Congress, 8th – 9th May 2018, London, UK.Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.

Including 5 interactive streams:

  • Large Molecule Drug Formulation
  • Advances in Drug Delivery
  • Drug Delivery Devices
  • Small Molecule Drug Formulation
  • Bioanalysis and Stabilisation

Featuring exclusive presentations on regulatory updates and targeted therapies

Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery Congress covering the development and formulation of inhaled therapies and inhalation devices & analytics.

View the Agenda here: http://bit.ly/2zFQHzn


Free Pre-Congress Webinar Recordings

Advances in Small Drugs Formulation Research
David Elder, Director, Product Development, GlaxoSmithKline & René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S

Download today for free: http://bit.ly/2zD5R8v

API Physical Form Selection: Chances vs Challenges For Formulation Development

Axel Becker, Senior Scientist, Merck KGaA

Download today for free: http://bit.ly/2hvgW0H

For further information, prices & discounts please contact g.alonso@oxfordglobal.co.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>


News and Press Releases

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

PHILADELPHIA – March 30, 2020 – ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global ‘stay home’ mandates. The solution enables clinician-administered ECG readings ─ using ERT’s provisioned, FDA-cleared devices or other investigative site–owned equipment ─ to evaluate the safety of new vaccines and medical treatments from patients’ homes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement